BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15753667)

  • 1. Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients.
    Costello A; Rey-Hipolito C; Patel A; Oakley K; Vasco V; Calabria C; Tuttle RM; Francis GL
    Thyroid; 2005 Feb; 15(2):105-13. PubMed ID: 15753667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
    Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated thyroid carcinomas from children and adolescents express IGF-I and the IGF-I receptor (IGF-I-R). Cancers with the most intense IGF-I-R expression may be more aggressive.
    Gydee H; O'Neill JT; Patel A; Bauer AJ; Tuttle RM; Francis GL
    Pediatr Res; 2004 Apr; 55(4):709-15. PubMed ID: 14973173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents.
    Shah R; Banks K; Patel A; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4391-7. PubMed ID: 12213904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.
    Patel A; Jhiang S; Dogra S; Terrell R; Powers PA; Fenton C; Dinauer CA; Tuttle RM; Francis GL
    Pediatr Res; 2002 Nov; 52(5):737-44. PubMed ID: 12409522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma.
    Ramirez R; Hsu D; Patel A; Fenton C; Dinauer C; Tuttle RM; Francis GL
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):635-44. PubMed ID: 11106926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.
    Straight AM; Patel A; Fenton C; Dinauer C; Tuttle RM; Francis GL
    J Endocrinol Invest; 2002 Apr; 25(4):302-8. PubMed ID: 12030599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults.
    Fenton C; Patel A; Dinauer C; Robie DK; Tuttle RM; Francis GL
    Thyroid; 2000 Apr; 10(4):349-57. PubMed ID: 10807064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.
    Soh EY; Duh QY; Sobhi SA; Young DM; Epstein HD; Wong MG; Garcia YK; Min YD; Grossman RF; Siperstein AE; Clark OH
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3741-7. PubMed ID: 9360534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin and the erythropoietin receptor are expressed by papillary thyroid carcinoma from children and adolescents. Expression of erythropoietin receptor might be a favorable prognostic indicator.
    Eccles TG; Patel A; Verma A; Nicholson D; Lukes Y; Tuttle RM; Francis GL
    Ann Clin Lab Sci; 2003; 33(4):411-22. PubMed ID: 14584755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in poorly differentiated papillary thyroid carcinomas.
    Fluge Ø; Bruland O; Akslen LA; Lillehaug JR; Varhaug JE
    Thyroid; 2006 Feb; 16(2):161-75. PubMed ID: 16676402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic localization of the paired box gene, Pax-8, is found in pediatric thyroid cancer and may be associated with a greater risk of recurrence.
    Scouten WT; Patel A; Terrell R; Burch HB; Bernet VJ; Tuttle RM; Francis GL
    Thyroid; 2004 Dec; 14(12):1037-46. PubMed ID: 15650356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
    Yamamoto S; Tomita Y; Uruno T; Hoshida Y; Qiu Y; Iizuka N; Nakamichi I; Miyauchi A; Aozasa K
    Ann Surg Oncol; 2005 Nov; 12(11):925-34. PubMed ID: 16189643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is thyroid cancer recurrence risk increased after transplantation?
    Tisset H; Kamar N; Faugeron I; Roy P; Pouteil-Noble C; Klein M; Mourad G; Drui D; Do Cao C; Leenhardt L; Allix I; Bonichon F; Morelon E; Leboulleux S; Kelly A; Niccoli P; Toubert ME; Frimat L; Vantyghem MC; Bournaud C; Schlumberger M; Borson-Chazot F;
    J Clin Endocrinol Metab; 2013 Oct; 98(10):3981-8. PubMed ID: 23884779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of sialic fibronectin correlates with lymph node metastasis of thyroid malignant neoplasmas.
    Takeyama H; Kyoda S; Okamoto T; Manome Y; Watanabe M; Kinoshita S; Uchida K; Sakamoto A; Morikawa T
    Anticancer Res; 2011 Apr; 31(4):1395-8. PubMed ID: 21508391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation.
    Cunha LL; Marcello MA; Morari EC; Nonogaki S; Conte FF; Gerhard R; Soares FA; Vassallo J; Ward LS
    Endocr Relat Cancer; 2013 Feb; 20(1):103-10. PubMed ID: 23193072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.